MedTrace Logo

Rapid Renal Sympathetic Denervation for Resistant Hypertension II

NCT01939392 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2015-08-18

No results posted yet for this study

Summary

This is a global, multi-center, prospective, randomized, controlled study of the safety and effectiveness of renal denervation with the OneShot Renal Denervation System in patients with uncontrolled hypertension.

Conditions

Interventions

DEVICE

Renal Denervation (OneShot™ Renal Denervation System)

Sponsors & Collaborators

  • Medtronic Endovascular

    lead INDUSTRY

Principal Investigators

  • Dierk Scheinert, MD · Park-Krankenhaus Liepzig

  • Guiseppe Mancia, MD · Universita Minano-Bicocca, Ospedale San Gerardo di Monza

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-09-30
Completion
2018-09-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01939392 on ClinicalTrials.gov